3,5,9-Trioxa-4-phosphapentacos-18-en-1-aminium, 4,7-dihydroxy-N,N,N-trimethyl-10-oxo-, inner salt, 4-oxide, (7R,18Z)-

LysoPC(16:1(9Z)) is a type of lysophosphatidylcholine that can be used to study spleen deficiency syndrome[1].

ChEBI: 1-[(9Z)-hexadecenoyl]-sn-glycero-3-phosphocholine is a 1-O-acyl-sn-glycero-3-phosphocholine in which the 1-acyl group is (9Z)-hexadecenoyl (palmitoleoyl). It has a role as a mouse metabolite and a human metabolite. It is a lysophosphatidylcholine 16:1, a 1-O-acyl-sn-glycero-3-phosphocholine and a [(9Z)-hexadecenoyl]-sn-glycero-3-phosphocholine. It is functionally related to a palmitoleic acid.

[1] Yang Xin, et al. Serum Metabonomics Analysis of Fuzi Lizhong Decoction for the Treatment of Splenasthenic Syndrome. Chromatographia.2017; 80(7), 1047–1059.
[2] MARCIN SZUSTAK*, EDYTA GENDASZEWSKA-DARMACH   Lysophosphatidylcholines Enriched with cis and trans Palmitoleic Acid Regulate Insulin Secretion via GPR119 Receptor[J]. ACS Medicinal Chemistry Letters, 2024, 15 2: 197-204. DOI: 10.1021/acsmedchemlett.3c00263